Target intelligence / Profile preview

Autolysin

Molecular classification
Enzyme, Cell wall hydrolase, Peptidoglycan hydrolase
01

Overview

Autolysin is a general term for a family of endogenous lytic enzymes found in bacteria that hydrolyze bonds within the peptidoglycan layer of their own cell walls. These enzymes are essential for normal bacterial physiology—enabling processes such as cell growth, division, separation of daughter cells after mitosis, peptidoglycan turnover during elongation or repair, biofilm formation/dispersal, competence development in some species, and programmed autolysis. There are multiple types of autolysins classified by their cleavage sites within the peptidoglycan matrix—including N-acetylglucosaminidases (e.g., LytD/CwlG), muramidases/lysozymes, acetyl-muramyl-L-alanine amidases (e.g., LytC/CwlB), and endopeptidases. Autolysins are present in all bacteria with a peptidoglycan-based cell wall but have been most studied in Gram-positive organisms like Staphylococcus aureus and Bacillus subtilis. Their activity is tightly regulated because uncontrolled action can lead to self-destruction. Inhibitors targeting these enzymes—such as complestatin or corbomycin—bind to either the enzyme itself or its substrate within the bacterial cell wall to prevent necessary remodeling steps; this results in inhibition of bacterial growth or survival. Because autolysins play roles both in normal physiology and virulence/pathogenicity—including biofilm development—they represent promising targets for novel antibacterial therapies designed either to kill pathogens directly or disrupt persistent infections associated with biofilms.

Other names
Autolysinsbacterial autolysinAtl (gene)AtlA (Staphylococcus aureus)LytD (CwlG)LytC (CwlB)N-acetylglucosaminidasemuramidaseacetyl-muramyl-L-alanine amidaseendopeptidase
02

Mechanism of action

Inhibition of autolysin activity prevents peptidoglycan remodeling in bacteria by binding to the cell wall substrate or directly inhibiting the enzyme’s catalytic domain; this blocks cell division and leads to bacteriostasis or death.

03

Biological functions

Cell wall remodelingCell division and separationPeptidoglycan turnover and recyclingBiofilm formation and dispersalBacterial cell growth and elongation
04

Disease associations

Infection (bacterial pathogenesis)Biofilm-associated infections
05

Safety considerations

Potential for off-target effects on beneficial microbiota if used systemically as antibacterial agents.
06

Interacting drugs

Complestatin

1 more in the full profile.

Beyond the preview

Go deeper on Autolysin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autolysin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call